contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


correction-updated-information-on-opps-reimbursement

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Paxman is active in scalp cooling, which is used for patients undergoing chemotherapy. The company's product Paxman Scalp Cooler is used to minimize hair loss in patients during treatment. The Scalp Cooler is a freestanding, mobile and electrically powered cooling unit that cools the patient's scalp via a cooling cap. Paxman was founded in 1996 and is headquartered in Karlshamn.

Paxman

We have identified an error in the previously published table regarding the coding for mechanical scalp cooling. The table has now been updated, and the corrected figures are marked in italic...

<div class="mfn-correction"><p>We have identified an error in the previously published table regarding the coding for mechanical scalp cooling. The table has now been updated, and the corrected figures are marked in italic text.</p></div><div class="mfn-body"><table><tbody><tr><td valign="middle" rowspan="1" colspan="1"><strong>Category I CPT codes for mechanical scalp cooling and brief description</strong></td><td valign="middle" rowspan="1" colspan="1"><strong>APC</strong></td><td valign="middle" rowspan="1" colspan="1"><strong>OPPS CY 2026 Rates</strong></td><td valign="middle" rowspan="1" colspan="1"><strong>MPFS CY 2026 Rates</strong></td><td valign="middle" rowspan="1" colspan="1"><strong>Example: MPFS rate for 6 treatments*</strong></td></tr><tr><td valign="middle" rowspan="1" colspan="1">97007 - Initial cap fitting and patient education</td><td valign="middle" rowspan="1" colspan="1"><em>1516</em></td><td valign="middle" rowspan="1" colspan="1"><em>$1,450.50</em></td><td valign="middle" rowspan="1" colspan="1">$1,883.43 per patient, per treatment cycle</td><td valign="middle" rowspan="1" colspan="1">$1,883.43</td></tr><tr><td valign="middle" rowspan="1" colspan="1">97008 - Pre-cooling period</td><td valign="middle" rowspan="1" colspan="1">N/A</td><td valign="middle" rowspan="1" colspan="1">N/A</td><td valign="middle" rowspan="1" colspan="1">$55.80 per treatment</td><td valign="middle" rowspan="1" colspan="1">$334.80</td></tr><tr><td valign="middle" rowspan="1" colspan="1">97009 - Post-infusion cooling, per each 30 minute period</td><td valign="middle" rowspan="1" colspan="1">N/A</td><td valign="middle" rowspan="1" colspan="1">N/A</td><td valign="middle" rowspan="1" colspan="1">$32.31 per unit, per treatment</td><td valign="middle" rowspan="1" colspan="1">$775.44</td></tr></tbody></table><p><em>*Average number of treatments per patient is six. Average post infusion cooling time is up to 120 minutes.</em></p><p>Learn more about Paxman’s Scalp Cooling System:&nbsp;<a rel="noopener" href="https://www.paxmanscalpcooling.com/">www.paxmanscalpcooling.com</a></p></div><div class="mfn-footer mfn-contacts mfn-2b75fe265c03"><p><strong class="mfn-heading-1">Contacts</strong></p><hr><p>Richard Paxman, CEO  <br>Tel: +44 7968 020641  <br>Email: richard@paxmanscalpcooling.com <br><a rel="noopener" href="http://www.paxman.se">www.paxman.se</a></p></div><div class="mfn-footer mfn-about mfn-b1f5e09eeff2"><p><strong class="mfn-heading-1">About Us</strong></p><hr><p>The Paxman Scalp Cooling System has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The concept behind the system came when the mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy-induced hair loss. In 2025, PAXMAN AB acquired Dignitana, merging to form a stronger united company.<br>Today, PAXMAN’s portfolio includes both the Paxman and DigniCap systems with several thousand installations in hospitals, clinics and treatment centres worldwide, reaffirming PAXMAN as the leading global supplier of Scalp Cooling technology. <br>PAXMAN AB (publ) has its headquarters in Karlshamn (Sweden). Subsidiaries of the PAXMAN Group are Paxman Coolers Limited (Huddersfield UK), Paxman Inc. (Houston, Texas US), Paxman Canada (Toronto, Ontario CA), Dignitana AB (Lund, Sweden), Dignitana Inc. (Dallas, TX US), and Dignitana S.r.l. (Milan, IT).</p><p>The PAXMAN share is listed on Nasdaq First North Growth Market.<br>FNCA Sweden AB is the company’s Certified Adviser.</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/cdb20315-fc65-43d2-87bc-d588e533c724/updated-information-on-opps-reimbursement.pdf" class="mfn-generated mfn-primary">Updated Information on OPPS Reimbursement</a></p></div>

Category I CPT codes for mechanical scalp cooling and brief description	APC	OPPS CY 2026 Rates	MPFS CY 2026 Rates	Example: MPFS rate for 6 treatments*
97007 - Initial cap fitting and patient education	1516	$1,450.50	$1,883.43 per patient, per treatment cycle	$1,883.43
97008 - Pre-cooling period	N/A	N/A	$55.80 per treatment	$334.80
97009 - Post-infusion cooling, per each 30 minute period	N/A	N/A	$32.31 per unit, per treatment	$775.44